A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant.
Vaccines (Basel). 2022 Mar 25;10(4):508. doi: 10.3390/vaccines10040508.
Vaccines (Basel). 2022.
PMID: 35455257
Free PMC article.